Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Dec 16, 2021; 9(35): 10816-10827
Published online Dec 16, 2021. doi: 10.12998/wjcc.v9.i35.10816
Table 1 Characteristics of the patients at baseline

Total
WOPC group
PC group
P
No. of cases20616640
Age (yr)62.0 ± 7.261.6 ± 7.363.5 ± 6.80.151
Sex 0.616
Male 175 (84.95%)140 (84.34%)35 (87.50%)
Female 31 (15.05%)26 (15.66%)5 (12.50%)
BMI (kg/m2)25.33 ± 2.8925.25 ± 2.8525.63 ± 3.040.461
Smoking history118 (57.56%)97 (58.79%)21 (52.50%)0.470
ASA grade0.521
Grade II157 (81.07%)136 (81.93%)31 (77.50%)
Grade III39 (18.93%)30 (18.07%)9 (22.50%)
Preoperative combined diseases
Hypertension 146 (70.87%)114 (68.67%)32 (80.0%)0.157
Diabetes mellitus74 (35.92%)61 (36.75%)13 (32.50%)0.615
Heart disease56 (27.18%)40 (24.10%)16 (40.0%)0.042a
Respiratory disease11 (5.34%)10 (6.02%)1 (2.50%)0.374
Neurological disease96 (46.60%)78 (46.99%)18 (45.0%)0.821
Kidney disease4 (1.94%)4 (2.41%)0 0.321
Degree of carotid artery stenosis on the surgical side0.449
Mild/moderate stenosis3 (1.46%)2 (1.20%)1 (2.5%)
Severe stenosis201 (97.57%)163 (98.19%)38 (95.0%)
Occlusion2 (0.97%)1 (0.60%)1 (2.50%)
Degree of carotid artery stenosis on the contralateral side0.146
Mild/moderate stenosis169 (85.35%)132 (83.02%)37 (94.87%)
Severe stenosis21 (10.61%)19 (11.95%)2 (5.13%)
Occlusion8 (4.04%)8 (5.03%)0
Operating time (min)141.33 ± 40.96138.39 ± 38.78153.57 ± 47.620.129
Duration of carotid artery occlusion (min)22.00 (18.0–44.0)22.00 (17.0–43.0)27.0 (18.50–49.50)0.328
Anesthesia method
TIVA163 (79.13%)129 (77.71%)34 (85.0%)0.309
Combined intravenous–inhalation anesthesia 43 (20.87%)37 (22.29%)6 (15.0%)
Intraoperative intake and output volume (mL)897.57 ± 333.40911.85 ± 331.01839.75 ± 341.010.221
meanSBP128.82 ± 12.92128.37 ± 12.77130.69 ± 13.540.309
SDSBP20.26 ± 4.9120.09 ± 5.0120.93 ± 4.480.333
CVSBP0.16 ± 0.040.16 ± 0.040.16 ± 0.030.550
meanDBP69.61 ± 7.8369.80 ± 7.7768.82 ± 8.140.480
SDDBP10.23 ± 2.7010.18 ± 2.8110.42 ± 2.260.612
CVDBP0.15 ± 0.040.15 ± 0.040.15 ± 0.040.372
Intraoperative use of vasopressors84 (40.78%)65 (39.16%)19 (47.50%)0.335
Intraoperative use of antihypertensive agents73 (35.44%)63 (37.95%)10 (25.0%)0.124